METHODS OF TREATING SACRAL INSUFFICIENCY FRACTURES AND DEVICES FOR PERFORMING SAME
20230363809 · 2023-11-16
Inventors
Cpc classification
A61B17/8811
HUMAN NECESSITIES
A61B34/20
HUMAN NECESSITIES
International classification
A61B17/88
HUMAN NECESSITIES
Abstract
A method for treatment of a sacral insufficiency fracture comprises a plurality of steps. A step is performed for placing an access device within a patient. Such placing of the access device includes causing a distal end portion of the access device to traverse through a sacroiliac joint of the patient and to traverse into the patient's sacrum until the distal end portion of the access device is within a region of the sacrum where a sacral insufficiency fracture is located. Thereafter, a step is performed for delivering bonding material though a portion of the access device into the sacrum at the region thereof where the sacral insufficiency fracture is located.
Claims
1. A method for treatment of a sacral insufficiency fracture, comprising: placing an access device within a patient, wherein said placing includes causing a distal end portion of the access device to traverse through a sacroiliac joint of the patient and to traverse into the patient's sacrum until the distal end portion of the access device is within a region of the sacrum where a sacral insufficiency fracture is located; and delivering bonding material though a portion of the access device into the sacrum at the region thereof where the sacral insufficiency fracture is located.
2. The method of claim 1 wherein said placing includes using only fluoroscopy for visualizing guidance of the access device.
3. The method of claim 2, further comprising: identifying an intended entry point for the access device, wherein said identifying includes determining a dorsal sacral line and a superior alar line in regard to the patient's pelvic anatomy; wherein the intended entry point is approximately 2-4 centimeters inferior to the dorsal sacral line and approximately 2-4 centimeters posterior to the superior alar line; and wherein placing the access device includes inserting the distal end portion of the access device through the intended entry point.
4. The method of claim 1 wherein said delivering includes: attaching a bonding material delivery device to a trocar of the access device; and using the bonding material delivery device to inject the bonding material into the region of the sacrum where the sacral insufficiency fracture is located.
5. The method of claim 4 wherein: the access device includes mating engagement structures that maintaining the stylet in a fixed axial position within the central passage of the trocar when the mating engagement structures are in an engaged configuration and enabling the stylet to be removing stylet from within the central passage of the trocar when the mating engagement structures are in a disengaged configuration; placing the access device includes maintaining the trocar and stylet in the engaged configuration; and removing the stylet from within the central passage of the trocar includes manipulating the trocar and stylet to be in the disengaged configuration.
6. The method of claim 1 wherein: the access device includes a trocar and a stylet having a portion thereof deposed within a central passage of the trocar; the distal end portion of the access device includes a distal end portion of the trocar; and said delivering includes removing the stylet from within the central passage of the trocar after placing an access device and attaching a bonding material delivery device to a proximate end portion of the trocar removing the stylet from within the central passage of the trocar.
7. The method of claim 1 wherein: the access device includes a trocar and a stylet having a portion thereof deposed within a central passage of the trocar; the distal end portion of the access device includes a distal end portion of the trocar; and said delivering includes removing stylet from within the central passage of the trocar while the distal end portion of the trocar remains positioned within the region of the sacrum where the sacral insufficiency fracture is located and attaching a bonding material delivery device to a trocar of the access device for enabling delivery of bonding material from the bonding material delivery device into the sacrum through the central passage of the of the trocar.
8. The method of claim 7, further comprising: inserting the stylet back into the central passage after injecting the bonding material; and removing the access device from the patient after the bonding material has one of fully and partially cured.
9. The method of claim 8 wherein: the access device includes mating engagement structures that maintaining the stylet in a fixed axial position within the central passage of the trocar when the mating engagement structures are in an engaged configuration and enabling the stylet to be removing stylet from within the central passage of the trocar when the mating engagement structures are in a disengaged configuration; placing the access device includes maintaining the trocar and stylet in the engaged configuration; and removing the stylet from within the central passage of the trocar includes manipulating the trocar and stylet to be in the disengaged configuration.
10. The method of claim 9, further comprising: identifying an intended entry point for the access device, wherein said identifying includes determining a dorsal sacral line and a superior alar line in regard to the patient's pelvic anatomy; wherein the intended entry point is approximately 2-4 centimeters inferior to the dorsal sacral line and approximately 2-4 centimeters posterior to the superior alar line; and wherein placing the access device includes inserting the distal end portion of the access device through the intended entry point.
11. The method of claim 1, further comprising: identifying an intended entry point for the access device, wherein said identifying includes determining a dorsal sacral line and a superior alar line in regard to the patient's pelvic anatomy; wherein the intended entry point is approximately 2-4 centimeters inferior to the dorsal sacral line and approximately 2-4 centimeters posterior to the superior alar line; and wherein placing the access device includes inserting the distal end portion of the access device through the intended entry point.
12. The method of claim 11 wherein placing the access device includes: urging the distal end portion of the access device into fixed engagement with an ilium wing of the patient's pelvic anatomy; in response to attaining fixed engagement with the ilium wing of the patient's pelvic anatomy, assessing at least one of inlet and outlet fluoroscopic views of the patient's pelvic anatomy to verify an intended trajectory of the distal end portion of the access device; and while viewing the distal end portion of the access device under live fluoroscopy, further urging the distal end portion of the access device until the distal end portion of the access device traverses the sacroiliac joint and protrudes into the sacrum.
13. The method of claim 12 wherein said placing includes using only fluoroscopy for visualizing guidance of the access device.
14. The method of claim 12 wherein: the access device includes a trocar and a stylet having a portion thereof deposed within a central passage of the trocar; the distal end portion of the access device includes a distal end portion of the trocar; and said delivering includes removing stylet from within the central passage of the trocar while the distal end portion of the trocar remains positioned within the region of the sacrum where the sacral insufficiency fracture is located and attaching a bonding material delivery device to a trocar of the access device for enabling delivery of bonding material from the bonding material delivery device into the sacrum through the central passage of the of the trocar.
15. The method of claim 14, further comprising: inserting the portion of the stylet back into the central passage after injecting the bonding material; and removing the access device from the patient after the bonding material has one of fully and partially cured.
16. The method of claim 15 wherein: the access device includes mating engagement structures that maintaining the stylet in a fixed axial position within the central passage of the trocar when the mating engagement structures are in an engaged configuration and enabling the stylet to be removing stylet from within the central passage of the trocar when the mating engagement structures are in a disengaged configuration; placing the access device includes maintaining the trocar and stylet in the engaged configuration; and removing the stylet from within the central passage of the trocar includes manipulating the trocar and stylet to be in the disengaged configuration.
17. The method of claim 16 wherein said placing includes using only fluoroscopy for visualizing guidance of the access device.
18. An access device adapted for treatment of a skeletal fracture, comprising: a trocar having a central passage; and a stylet having a portion thereof deposed within a central passage of the trocar, wherein the distal end portion of the access device includes a distal end portion of the trocar, wherein the stylet includes engagement structures that engage mating engagement structures of the trocar for maintaining the stylet in a fixed axial position within the central passage of the trocar when the mating engagement structures are in an engaged configuration and enabling the stylet to be removing stylet from within the central passage of the trocar when the mating engagement structures are in a disengaged configuration.
19. The access device of claim 17, further comprising: an adaptor configured for enabling attachment to a bonding material delivery device to the trocar to allow a bonding material to be delivered to an operative site through the central passage of the trocar.
20. The access device of claim 18 wherein the adapter is a threaded mounting body.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0021]
[0022]
[0023]
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
DETAILED DESCRIPTION
[0034] In general, embodiments of the disclosures made herein are directed to methods of surgical treatment for sacral insufficiency (SI) fractures and devices used in such methods. Because treatment methods in accordance with embodiments of the disclosures made herein preferably utilize only fluoroscopy, scheduling procedures for such treatment methods in an operating room (OR) or a procedure suite may be much more cost-effective and logistically much simpler. Accordingly, treatment methods in accordance with embodiments of the disclosures made herein allow for more readily-available sacral fracture treatment for patients and ultimately allow faster alleviation of suffering and lead to better outcomes both short-term and long-term.
[0035] Treatment methods in accordance with embodiments of the disclosures made herein may involve use of an access device 100 comprising a trocar unit 105 and a stylet unit 110, as shown in
[0036] The trocar handle 124 and the stylet handle 129 may be jointly configured to selectively allow the trocar unit 105 and the stylet unit 110 to be adjoined with each other (e.g., for inhibiting unrestricted axial displacement of the stylet 125 relative to the trocar unit 105) and to be separated from each other. For example, as best shown in
[0037] Preferably, as best shown in
[0038] Presented now is one specific embodiment of a SI fracture treatment method in accordance with the disclosures made herein (i.e., method 200), which utilizes the access device 100. The method 200 begins with the SI fracture patient 205 being placed in a prone position on an operating table 210, as shown in
[0039] A collection of images are taken of the patient's skeletal anatomy 215 in the pelvic region (i.e., pelvic anatomy) to aid in performing treatment of the SI fracture F (
[0040] Next, a puncture is made at the intended entry point IEP (e.g., with an 11 blade scalpel). Referring to
[0041] Once correct placement of the access device 100 relative to the bony confines of the sacrum S is verified (e.g., by 3 views of fluoroscopy—lateral, outlet and inlet), a bonding material (e.g., cement such as methlymethacrylate polymer) is injected through the central passage 135 of the trocar unit 105 under live fluoroscopy after removal of the stylet unit 110 from within the central passage 135. As filling of sacral fracture site begins, intermittent breaks in the bonding material delivery may be taken to obtain inlet and lateral fluoroscopic views to verify that none of the bonding material has exhibited extravasation beyond the sacral margins. Bonding material injection continues until visual confirmation of bonding material traversal of the SI fracture site indicated on pre-operative imaging has been achieved. Bonding material delivery is preferably performed under live fluoroscopy with intermittent images (e.g., lateral and inlet) to confirm absence of bonding material extravasation beyond the sacral confines. Additionally, the S1 foramen may be monitored (e.g., via outlet view) during injection to ensure no encroachment of the bonding material on the S1 foramen. Once adequate filling has been achieved, the stylet unit 110 is re-engaged with the trocar unit 105 to expel remaining cement preferably under live outlet fluoroscopy. The bonding material is allowed to sufficiently cure (e.g., approximately 1-2 minutes for methlymethacrylate polymer) and then the access device 100 is removed.
[0042] In one or more embodiments, a rotatory manual injector syringe (i.e., a bonding material delivery device) may be used to inject the bonding material. As discussed above, the bonding material the trocar unit 105 includes an adaptor 160 that provides for attachment to the bonding material delivery device 161 either directly or via a conduit (e.g., a piece of tubing). Prior to attachment of the bonding material delivery device to the trocar unit 105, the central passage 135 of the trocar unit 105 may be lightly filled with saline to allow air to be expelled (e.g., via elevated intravenous (IV) extension tubing). Optionally, a suitable visualization composition (e.g., Isovue 200M) may first be injected under live fluoroscopy to monitor an expected filling by the bonding material.
[0043] Although the invention has been described with reference to several exemplary embodiments, it is understood that the words that have been used are words of description and illustration, rather than words of limitation. Changes may be made within the purview of the appended claims, as presently stated and as amended, without departing from the scope and spirit of the invention in all its aspects. Although the invention has been described with reference to particular means, materials and embodiments, the invention is not intended to be limited to the particulars disclosed; rather, the invention extends to all functionally equivalent technologies, structures, methods and uses such as are within the scope of the appended claims.